Selank specifications and research profile
Specifications summary
| Designation | Synthetic tuftsin analogue heptapeptide |
|---|---|
| Also known as | Selank; TP-7 |
| Sequence / composition | Thr-Lys-Pro-Arg-Pro-Gly-Pro |
| Strength | 10mg × 10 vials |
| Presentation | 10-vial case |
| Purity | 99%+ HPLC |
| Storage | Store refrigerated at 2-8 C, protected from light. |
| COA | Batch document added when available |
Description and research context
Selank is a seven-residue synthetic analogue formed from the tuftsin sequence extended with Pro-Gly-Pro. It is studied as a regulatory-peptide reference in preclinical transcriptomic systems.
Published mouse, rat and cell-line studies have examined inflammatory and neurotransmission-associated gene panels. Reported changes vary with tissue, time point and experimental context.
Applications in research
- Tuftsin-analogue and fragment comparisons
- Cytokine and chemokine gene-expression panels
- GABAergic neurotransmission-associated transcription studies
Precautions and interpretation
For controlled laboratory research only. Not for human or veterinary use. The cited findings come from specific biochemical, cellular, structural or preclinical models and must not be treated as usage guidance or evidence of a defined outcome outside those models.
Selank research record
Clear product, batch, storage, dispatch and document information for this 10-vial case.
Research context
A synthetic tuftsin analogue studied in preclinical gene-expression models involving inflammatory and neurotransmission-associated pathways.
Product record
The listing identifies the presentation, specification, storage record, dispatch status, and COA availability for the relevant product or batch.
Use restriction
For laboratory research use only. Not for human or veterinary consumption. No use instructions or therapeutic guidance is provided.